Chromatin Regulation / Acetylation
PRMT1 (F339) Antibody
|
イイネ!(2)
|
|
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #2453S | 100 μL | 46,000 | |
|
PRMT1抗体製品一覧
2453 の推奨プロトコール
最適な結果を得るために:Cell Signaling Technology (CST) 社は、各製品の推奨プロトコールを使用することを強くお薦めいたします。
推奨プロトコールはCST社内試験の徹底的なバリデーションに基づいて作成されておりますので、正確かつ再現性の高い結果が得られます。
注:各製品に最適化されたプロトコールをリンクしています。
| | |
-
2453:
-
Western Blotting
| 用途(希釈倍率) | |
| ウエスタンブロッティング(1:1,000) |
| 特異性・感度 | |
| 内在性レベルのPRMT1 タンパク質(3つ全てのアイソフォーム)を検出します。他のPRMT タンパク質とは交差しません。 |
| 使用抗原 | |
| ヒトのPRMT1 タンパク質のC末端配列(合成ペプチド) |
| ※括弧付きの動物種は配列が100%相同であるため反応すると推定されます。 |
Western Blotting

Western blot analysis of cell lysates from A549, NIH/3T3, H-4-II-E and COS cells using PRMT1 Antibody.
Protein arginine N-methyltransferase 1 (PRMT1) is a member of the protein arginine N-methyltransferase (PRMT) family of proteins that catalyze the transfer of a methyl group from S-adenosylmethionine (AdoMet) to a guanidine nitrogen of arginine (1). Though all PRMT proteins catalyze the formation of mono-methyl arginine, Type I PRMTs (PRMT1, 3, 4, and 6) add an additional methyl group to produce an asymmetric di-methyl arginine while Type II PRMTs (PRMT 5 and 7) produce symmetric di-methyl arginine (1). Mono-methyl arginine, but not di-methyl arginine, can be converted to citrulline through deimination catalyzed by enzymes such as PADI4 (2). Most PRMTs, including PRMT1, methylate arginine residues found within glycine-arginine rich (GAR) protein domains, such as RGG, RG, and RXR repeats (1). However, PRMT4/CARM1 and PRMT5 methylate arginine residues within PGM (proline-, glycine-, methionine-rich) motifs (3). PRMT1 methylates Arg3 of histone H4 and cooperates synergistically with p300/CBP to enhance transcriptional activation by nuclear receptor proteins (4-6). In addition, PRMT1 methylates many non-histone proteins, including the orphan nuclear receptor HNF4 (6), components of the heterogeneous nuclear ribonucleoprotein (hnRNP) particle (7), the RNA binding protein Sam68 (8), interleukin enhancer-binding factor 3 (ILF3) (9) and interferon-α and β receptors (10). These interactions suggest additional functions in transcriptional regulation, mRNA processing and signal transduction. Alternative mRNA splicing produces three enzymatically active PMRT1 isoforms that differ in their amino-terminal regions (11). PRMT1 is localized to the nucleus or cytoplasm, depending on cell type (12,13) and appears in many distinct protein complexes. ILF3, TIS21 and the leukemia-associated BTG1 proteins bind PRMT1 to regulate its methyltransferase activity (9,14).
-
Bedford, M.T. and Richard, S. (2005) Mol. Cell 18, 263-272.
-
Wang, Y. et al. (2004) Science 306, 279-283.
-
Cheng, D. et al. (2007) Mol. Cell 25, 71-83.
-
Wang, H. et al. (2001) Science 293, 853-857.
-
Strahl, B.D. et al. (2001) Curr. Biol. 11, 996-1000.
-
Barrero, M.J. and Malik, S. (2006) Mol. Cell 24, 233-243.
-
Nichols, R.C. et al. (2000) Exp. Cell Res. 256, 522-532.
-
Côté, J. et al. (2003) Mol. Biol. Cell 14, 274-287.
-
Tang, J. et al. (2000) J. Biol. Chem. 275, 19866-19876.
-
Abramovich, C. et al. (1997) EMBO J. 16, 260-266.
-
Scorilas, A. et al. (2000) Biochem. Biophys. Res. Commun. 278, 349-359.
-
Frankel, A. et al. (2002) J. Biol. Chem. 277, 3537-3543.
-
Herrmann, F. et al. (2005) J. Biol. Chem. 280, 38005-38010.
-
Lin, W.J. et al. (1996) J. Biol. Chem. 271, 15034-15044.